NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 182 filers reported holding NEVRO CORP in Q2 2022. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,269,998 | -30.7% | 118,106 | -8.4% | 0.00% | – |
| Q2 2023 | $3,276,766 | -28.1% | 128,905 | +2.2% | 0.00% | -100.0% |
| Q1 2023 | $4,560,000 | +7651.9% | 126,124 | -91.5% | 0.00% | -87.5% |
| Q4 2022 | $58,824 | -99.9% | 1,485,471 | -7.1% | 0.01% | -27.3% |
| Q3 2022 | $74,480,000 | +23.4% | 1,598,269 | +16.1% | 0.01% | +37.5% |
| Q2 2022 | $60,358,000 | -38.9% | 1,377,111 | +0.8% | 0.01% | -33.3% |
| Q1 2022 | $98,815,000 | +3.6% | 1,366,186 | +16.1% | 0.01% | +9.1% |
| Q4 2021 | $95,363,000 | -30.3% | 1,176,299 | +0.1% | 0.01% | -35.3% |
| Q3 2021 | $136,811,000 | -29.6% | 1,175,552 | +0.3% | 0.02% | -26.1% |
| Q2 2021 | $194,295,000 | +14.7% | 1,171,934 | -3.5% | 0.02% | 0.0% |
| Q1 2021 | $169,374,000 | -12.1% | 1,214,150 | +9.0% | 0.02% | -17.9% |
| Q4 2020 | $192,765,000 | +34.9% | 1,113,604 | +8.1% | 0.03% | +16.7% |
| Q3 2020 | $142,936,000 | +20.6% | 1,030,397 | +3.8% | 0.02% | +4.3% |
| Q2 2020 | $118,560,000 | +5.3% | 992,382 | -11.9% | 0.02% | -11.5% |
| Q1 2020 | $112,559,000 | -11.6% | 1,125,810 | +3.9% | 0.03% | +8.3% |
| Q4 2019 | $127,359,000 | +16.1% | 1,083,536 | -15.1% | 0.02% | +9.1% |
| Q3 2019 | $109,660,000 | +27.0% | 1,275,556 | -4.1% | 0.02% | +29.4% |
| Q2 2019 | $86,318,000 | +12.1% | 1,330,638 | +8.0% | 0.02% | +6.2% |
| Q1 2019 | $76,989,000 | +88.4% | 1,231,615 | +17.2% | 0.02% | +77.8% |
| Q4 2018 | $40,860,000 | -31.8% | 1,050,660 | -0.1% | 0.01% | -18.2% |
| Q3 2018 | $59,947,000 | -17.3% | 1,051,674 | +15.9% | 0.01% | -26.7% |
| Q2 2018 | $72,449,000 | +0.9% | 907,315 | +9.5% | 0.02% | 0.0% |
| Q1 2018 | $71,797,000 | +29.8% | 828,400 | +3.4% | 0.02% | +25.0% |
| Q4 2017 | $55,311,000 | -13.2% | 801,148 | +11.8% | 0.01% | -14.3% |
| Q3 2017 | $63,701,000 | +29.2% | 716,472 | +8.2% | 0.01% | +27.3% |
| Q2 2017 | $49,302,000 | -14.8% | 662,390 | +7.3% | 0.01% | -15.4% |
| Q1 2017 | $57,833,000 | +21.3% | 617,206 | -5.9% | 0.01% | +18.2% |
| Q4 2016 | $47,669,000 | -26.5% | 656,085 | +5.6% | 0.01% | -31.2% |
| Q3 2016 | $64,859,000 | +6.4% | 621,308 | -24.8% | 0.02% | +6.7% |
| Q2 2016 | $60,939,000 | +27.0% | 826,197 | -3.1% | 0.02% | +25.0% |
| Q1 2016 | $47,976,000 | -13.6% | 852,758 | +3.7% | 0.01% | -14.3% |
| Q4 2015 | $55,497,000 | +47.5% | 822,063 | +1.4% | 0.01% | +40.0% |
| Q3 2015 | $37,626,000 | -14.6% | 811,071 | -1.0% | 0.01% | 0.0% |
| Q2 2015 | $44,047,000 | +110.1% | 819,479 | +87.3% | 0.01% | +100.0% |
| Q1 2015 | $20,966,000 | +49.3% | 437,437 | +20.4% | 0.01% | +66.7% |
| Q4 2014 | $14,045,000 | – | 363,234 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 403,424 | $46,950,000 | 6.74% |
| HealthCor Management, L.P. | 529,230 | $61,592,000 | 2.66% |
| Sante Capital Fund, LP | 18,963 | $2,207,000 | 2.04% |
| Jackson Square Partners, LLC | 2,452,497 | $285,421,000 | 1.81% |
| Altium Capital Management LP | 51,000 | $5,935,000 | 1.56% |
| Rock Springs Capital Management LP | 635,700 | $73,983,000 | 1.56% |
| PFM Health Sciences, LP | 392,786 | $45,712,000 | 1.34% |
| Redmile Group, LLC | 542,932 | $63,186,000 | 1.10% |
| Connacht Asset Management LP | 13,555 | $1,578,000 | 1.02% |
| Integral Health Asset Management, LLC | 30,000 | $3,491,000 | 1.00% |